Literature DB >> 4115718

Complete hepatic dearterialization for primary carcinoma of the liver. Report of twenty-four patients.

M Balasegaram.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 4115718     DOI: 10.1016/0002-9610(72)90038-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  17 in total

1.  Treatment of unresectable hepatocellular carcinoma: results of a randomized controlled trial.

Authors:  E C Lai; T K Choi; S W Tong; G B Ong; J Wong
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

2.  The prevention of arterial collaterals after repeated temporary blockade of the hepatic artery in pigs.

Authors:  B G Persson; B Jeppsson; L Andersson; S E Strand; L Ekelund; S Bengmark
Journal:  World J Surg       Date:  1987-10       Impact factor: 3.352

3.  Metabolic changes after hepatic dearterialization in man.

Authors:  N Nagasue
Journal:  Jpn J Surg       Date:  1973-09

4.  Results of surgical treatments of primary hepatocellular carcinoma: some aspects to improve long-term survival.

Authors:  E Okamoto; N Tanaka; N Yamanaka; A Toyosaka
Journal:  World J Surg       Date:  1984-06       Impact factor: 3.352

5.  Functional effect of collateral circulation after dearterialization of the liver.

Authors:  T Yokota
Journal:  Jpn J Surg       Date:  1979-12

6.  Transient hepatic dearterialization followed by regional intra-arterial 5-fluorouracil infusion as treatment for liver tumors.

Authors:  E P Dahl; P E Frelund; U Tylén; S Bengmark
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

7.  Metastatic carcinoid to the liver treated by hepatic dearterialization.

Authors:  W V McDermott; T W Hensle
Journal:  Ann Surg       Date:  1974-09       Impact factor: 12.969

8.  [Importance of graft arterialization in rat liver transplantation].

Authors:  T S Lie; H H Hansen; K J Niehaus
Journal:  Langenbecks Arch Chir       Date:  1983

Review 9.  Current treatment modalities for hepatocellular carcinoma.

Authors:  D G Farmer; M H Rosove; A Shaked; R W Busuttil
Journal:  Ann Surg       Date:  1994-03       Impact factor: 12.969

10.  A non-resectable hepatoma after hepatic artery ligation combined with infusion chemotherapy--an eight-year survival.

Authors:  K Nakakuma; S Tashiro; T Hiraoka; T Konno; I Yokoyama
Journal:  Jpn J Surg       Date:  1981-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.